End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1.23 TND | -3.91% | -.--% | -2.38% |
2023 | Sanimed Société Anonyme Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
2023 | Sanimed Société Anonyme Reports Earnings Results for the Full Year Ended December 31, 2022 | CI |
Sales 2021 | 63.3M 20.23M 1.69B | Sales 2022 | 58.16M 18.58M 1.55B | Capitalization | 21.2M 6.78M 565M |
---|---|---|---|---|---|
Net income 2021 | - 0 0 | Net income 2022 | -9M -2.88M -240M | EV / Sales 2021 | 1.96 x |
Net Debt 2021 | 96.21M 30.74M 2.56B | Net Debt 2022 | 97.46M 31.14M 2.6B | EV / Sales 2022 | 2.04 x |
P/E ratio 2021 |
-142
x | P/E ratio 2022 |
-2.13
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 24.34% |
1 day | -3.91% | ||
3 months | -8.89% | ||
6 months | -34.92% | ||
Current year | -2.38% |
Managers | Title | Age | Since |
---|---|---|---|
Mouldi Bel Haj
CEO | Chief Executive Officer | - | - |
Nizar Rezgui
PRN | Corporate Officer/Principal | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | - | - | |
Hédi ben Cherif
BRD | Director/Board Member | - | - |
Director/Board Member | - | - |
1st Jan change | Capi. | |
---|---|---|
-2.38% | 4.87M | |
-27.40% | 1.15B | |
-8.13% | 1.12B | |
+2.04% | 1.04B | |
+14.85% | 691M | |
-26.72% | 309M | |
+14.56% | 222M | |
+39.74% | 211M | |
+16.04% | 180M | |
-2.68% | 90.7M |
- Stock Market
- Equities
- SANIMED Stock